| Cell origins of high-grade serous ovarian cancer J Kim, EY Park, O Kim, JM Schilder, DM Coffey, CH Cho, RC Bast Jr Cancers 10 (11), 433, 2018 | 244 | 2018 |
| Targeting of miR34a–NOTCH1 axis reduced breast cancer stemness and chemoresistance EY Park, ES Chang, EJ Lee, HW Lee, HG Kang, KH Chun, YM Woo, ... Cancer research 74 (24), 7573-7582, 2014 | 190 | 2014 |
| MicroRNA 34c gene down-regulation via DNA methylation promotes self-renewal and epithelial-mesenchymal transition in breast tumor-initiating cells F Yu, Y Jiao, Y Zhu, Y Wang, J Zhu, X Cui, Y Liu, Y He, EY Park, H Zhang, ... Journal of biological chemistry 287 (1), 465-473, 2012 | 182 | 2012 |
| Inhibition of aerobic glycolysis represses Akt/mTOR/HIF-1α axis and restores tamoxifen sensitivity in antiestrogen-resistant breast cancer cells YM Woo, Y Shin, EJ Lee, S Lee, SH Jeong, HK Kong, EY Park, HK Kim, ... PloS one 10 (7), e0132285, 2015 | 143 | 2015 |
| De novo mutations in SON disrupt RNA splicing of genes essential for brain development and metabolism, causing an intellectual-disability syndrome JH Kim, DN Shinde, MRF Reijnders, NS Hauser, RL Belmonte, GR Wilson, ... The American Journal of Human Genetics 99 (3), 711-719, 2016 | 109 | 2016 |
| Cyst formation in kidney via B-Raf signaling in the PKD2 transgenic mice EY Park, YH Sung, MH Yang, JY Noh, SY Park, TY Lee, YJ Yook, KH Yoo, ... Journal of Biological Chemistry 284 (11), 7214-7222, 2009 | 86 | 2009 |
| A novel miR-34a target, protein kinase D1, stimulates cancer stemness and drug resistance through GSK3/β-catenin signaling in breast cancer EY Park, ES Chang, HG Kang, Y Koo, EJ Lee, JY Ko, HK Kong, KH Chun, ... Oncotarget 7 (12), 14791, 2016 | 79 | 2016 |
| SON and its alternatively spliced isoforms control MLL complex-mediated H3K4me3 and transcription of leukemia-associated genes JH Kim, MC Baddoo, EY Park, JK Stone, H Park, TW Butler, G Huang, ... Molecular cell 61 (6), 859-873, 2016 | 54 | 2016 |
| Genome-wide methylation profiling of ADPKD identified epigenetically regulated genes associated with renal cyst development YM Woo, JB Bae, YH Oh, YG Lee, MJ Lee, EY Park, JK Choi, S Lee, ... Human genetics 133, 281-297, 2014 | 54 | 2014 |
| Transcription factors Sp1 and Sp3 regulate expression of human ABCG2 gene and chemoresistance phenotype WJ Yang, MJ Song, EY Park, JJ Lee, JH Park, K Park, JH Park, HP Kim Molecules and cells 36, 368-375, 2013 | 53 | 2013 |
| Effects of specific genes activating RAGE on polycystic kidney disease EY Park, MJ Seo, JH Park American journal of nephrology 32 (2), 169-178, 2010 | 45 | 2010 |
| Targeting progesterone signaling prevents metastatic ovarian cancer O Kim, EY Park, SY Kwon, S Shin, RE Emerson, YH Shin, FJ DeMayo, ... Proceedings of the National Academy of Sciences 117 (50), 31993-32004, 2020 | 38 | 2020 |
| Profiling of miRNAs and target genes related to cystogenesis in ADPKD mouse models YM Woo, DY Kim, NJ Koo, YM Kim, S Lee, JY Ko, Y Shin, BH Kim, H Mun, ... Scientific Reports 7 (1), 14151, 2017 | 34 | 2017 |
| In vivo modeling of metastatic human high-grade serous ovarian cancer in mice O Kim, EY Park, DL Klinkebiel, SD Pack, YH Shin, Z Abdullaev, ... PLoS genetics 16 (6), e1008808, 2020 | 33 | 2020 |
| Impact of miR‐192 and miR‐194 on cyst enlargement through EMT in autosomal dominant polycystic kidney disease DY Kim, YM Woo, S Lee, S Oh, Y Shin, JO Shin, EY Park, JY Ko, EJ Lee, ... The FASEB Journal 33 (2), 2870-2884, 2019 | 32 | 2019 |
| SON haploinsufficiency causes impaired pre-mRNA splicing of CAKUT genes and heterogeneous renal phenotypes JH Kim, EY Park, D Chitayat, DL Stachura, J Schaper, K Lindstrom, ... Kidney international 95 (6), 1494-1504, 2019 | 30 | 2019 |
| PEP-1-PON1 protein regulates inflammatory response in raw 264.7 macrophages and ameliorates inflammation in a TPA-induced animal model MJ Kim, HJ Jeong, DW Kim, EJ Sohn, HS Jo, DS Kim, HA Kim, EY Park, ... PloS one 9 (1), e86034, 2014 | 30 | 2014 |
| A case of huge sclerosing stromal tumor of the ovary weighing 10 kg in a 71-year-old postmenopausal woman HS Youm, DS Cha, KH Han, EY Park, NN Hyon, Y Chong Journal of gynecologic oncology 19 (4), 270-274, 2008 | 28 | 2008 |
| Soluble receptor for advanced glycation end products inhibits disease progression in autosomal dominant polycystic kidney disease by down‐regulating cell proliferation EJ Lee, EY Park, HW Mun, ES Chang, JY Ko, DY Kim, JH Park The FASEB Journal 29 (8), 3506-3514, 2015 | 25 | 2015 |
| Polycystic kidney disease and therapeutic approaches EY Park, YM Woo, JH Park BMB reports 44 (6), 359-368, 2011 | 24 | 2011 |
Hyunkyung KongNational Cancer Institute, National Institutes of Health在 nih.gov 的电子邮件经过验证
